Back to today’s briefing

Story perspectives

Revolutionary Trial Aims to 'Switch Off' Rheumatoid Arthritis

3/26/2025

23 4

Summary

Story summary

A groundbreaking trial in England seeks to "switch off" rheumatoid arthritis by retraining white blood cells to protect healthy tissues. Spearheaded by Prof John Isaacs at Newcastle University, the AuToDeCRA-2 study shows promising initial results that could transform the lives of millions. However, more research is essential before this innovative treatment becomes widely available, potentially within 5-10 years.

1 of 1

Story summary

A groundbreaking trial in England seeks to "switch off" rheumatoid arthritis by retraining white blood cells to protect healthy tissues. Spearheaded by Prof John Isaacs at Newcastle University, the AuToDeCRA-2 study shows promising initial results that could transform the lives of millions. However, more research is essential before this innovative treatment becomes widely available, potentially within 5-10 years.